Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON (JNJ)

232
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

08/21/2012 | 07:13pm US/Eastern
   By Ben Fox Rubin 
 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Latest news on JOHNSON & JOHNSON
2h ago JOHNSON & JOHNSON : J&J TO SELL TWO BRANDS IN INDIA FOR Rs300 CRORE
2h ago JOHNSON & JOHNSON : Innovation Debuts Asia Pacific Innovation Center
1d ago JOHNSON & JOHNSON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
1d ago JOHNSON & JOHNSON : National Survey Highlights Burden of Knee Osteoarthritis in ..
2d ago JOHNSON & JOHNSON : $250,000 Awarded to 24th Annual TYLENOL® Future Care Scholar..
2d ago JOHNSON & JOHNSON : Ethicon Launches ECHELON FLEX™ GST SYSTEM with Advance..
2d ago JOHNSON & JOHNSON : Studies from Johnson & Johnson Further Understanding of Stap..
2d ago JOHNSON & JOHNSON : New market study, "Johnson & Johnson Inc in Tissue and Hygie..
3d ago JOHNSON & JOHNSON : Innovation Launches Asia Pacific Innovation Center and Annou..
3d ago JOHNSON & JOHNSON : Announces Major Commitment to Speed Ebola Vaccine Developmen..
Advertisement
Chart
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF